Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for CureVac (CVAC) over the last 6 years, with Q3 2025 value amounting to -$376435.7.

  • CureVac's Cash from Investing Activities rose 8960.99% to -$376435.7 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year increase of 8343.2%. This contributed to the annual value of -$19.7 million for FY2024, which is 6681.5% up from last year.
  • According to the latest figures from Q3 2025, CureVac's Cash from Investing Activities is -$376435.7, which was up 8960.99% from -$1.8 million recorded in Q2 2025.
  • CureVac's Cash from Investing Activities' 5-year high stood at $106.6 billion during Q4 2021, with a 5-year trough of -$88.7 billion in Q2 2021.
  • In the last 5 years, CureVac's Cash from Investing Activities had a median value of -$14.1 million in 2023 and averaged -$337.5 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 32159384.17% in 2021, then tumbled by 4386160.97% in 2022.
  • Quarter analysis of 5 years shows CureVac's Cash from Investing Activities stood at $106.6 billion in 2021, then plummeted by 100.02% to -$21.4 million in 2022, then increased by 27.43% to -$15.5 million in 2023, then soared by 82.29% to -$2.7 million in 2024, then soared by 86.29% to -$376435.7 in 2025.
  • Its Cash from Investing Activities was -$376435.7 in Q3 2025, compared to -$1.8 million in Q2 2025 and -$537513.0 in Q1 2025.